Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Weisdorf, 2008, Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival., Biol Blood Marrow Transplant, 14, 748, 10.1016/j.bbmt.2008.04.003 Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT., Blood, 106, 2912, 10.1182/blood-2005-05-2004 Armand, 2012, A disease risk index for patients undergoing allogeneic stem cell transplantation., Blood, 120, 905, 10.1182/blood-2012-03-418202 Slack, 2013, Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch., Biol Blood Marrow Transplant, 19, 1167, 10.1016/j.bbmt.2013.05.001 Thanarajasingam, 2013, Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation., Biol Blood Marrow Transplant, 19, 1713, 10.1016/j.bbmt.2013.09.011 Horowitz, 2008, The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research., Bone Marrow Transplant, 42, S1, 10.1038/bmt.2008.101 Armand, 2012, Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study., Biol Blood Marrow Transplant, 18, 280, 10.1016/j.bbmt.2011.07.024 Armand, 2010, Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes., Bone Marrow Transplant, 45, 877, 10.1038/bmt.2009.253 Harrell, 1984, Regression modelling strategies for improved prognostic prediction., Stat Med, 3, 143, 10.1002/sim.4780030207 Armand, 2007, Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation., Biol Blood Marrow Transplant, 13, 655, 10.1016/j.bbmt.2007.01.079 Grimwade, 2010, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials., Blood, 116, 354, 10.1182/blood-2009-11-254441 Greenberg, 1997, International scoring system for evaluating prognosis in myelodysplastic syndromes., Blood, 89, 2079, 10.1182/blood.V89.6.2079 Parimon, 2006, A risk score for mortality after allogeneic hematopoietic cell transplantation., Ann Intern Med, 144, 407, 10.7326/0003-4819-144-6-200603210-00007 Anasetti, 2012, Peripheral-blood stem cells versus bone marrow from unrelated donors., N Engl J Med, 367, 1487, 10.1056/NEJMoa1203517 Mohty, 2010, Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation., Blood, 116, 4439, 10.1182/blood-2010-02-266551 Postow, 2011, Philadelphia chromosome is not an adverse prognostic factor in acute lymphoblastic leukemia after myeloablative allogeneic hematopoietic stem cell transplantation [abstract]., Biol Blood Marrow Transplant, 17, S244, 10.1016/j.bbmt.2010.12.276 Gooley, 2010, Reduced mortality after allogeneic hematopoietic-cell transplantation., N Engl J Med, 363, 2091, 10.1056/NEJMoa1004383